Home
About
Overview
Sharing Data
ORCID
Help
History (67)
The role of interleukin-1 in the pathogenesis of rheumatoid arthritis.
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial.
Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism.
Diffusion-tensor imaging in septo-optic dysplasia.
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
See All 67 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Kay J, Cross RK, Feldman SR, Park Y, Hanauer SB. Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases. Adv Ther. 2024 02; 41(2):509-533.
View in:
PubMed
subject areas
Adalimumab
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Crohn Disease
Humans
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD